Foldexa Beta is Now Live — Early Access Open

Today, Foldexa opens its doors. After 14 months of development and 400+ internal design campaigns run with our KAIST and Solbridge partners, we are ready for early access.

What Is Available Today

• Pipeline 1: DiffAb CDR Redesign — submit any antigen PDB, redesign any combination of CDR loops, receive AlphaFold2-validated candidates
• Pipeline 2: RFdiffusion De Novo Scaffold — define a target motif, generate novel protein scaffolds, filter by self-consistency
• Structure Viewer: interactive 3D visualization of all candidate structures in-browser (no PyMOL required)
• Results Dashboard: sortable by Foldexa Score, pLDDT, iptm; downloadable PDB files
• REST API (Premium plan): programmatic job submission and result retrieval
• 5 free design campaigns for all new accounts (no credit card required)

How Early Access Works

We are rolling out access in batches of 200 users per week to ensure infrastructure stability. Sign up at foldexa.com/beta-access — you will receive an invite within 48 hours during the first wave.

What Is Coming Next

“Foldexa compresses a 3-month phage display campaign into a Tuesday afternoon. That is the kind of acceleration that changes what is possible in a small lab.”

— Early access researcher, Solbridge International School of Business